These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1991926)

  • 1. The effect of the oral leukotriene antagonist, ICI 204,219, on leukotriene D4 and histamine-induced cutaneous vascular reactions in man.
    Bernstein JA; Greenberger PA; Patterson R; Glass M; Krell R; Thyrum PT
    J Allergy Clin Immunol; 1991 Jan; 87(1 Pt 1):93-8. PubMed ID: 1991926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219.
    Smith LJ; Geller S; Ebright L; Glass M; Thyrum PT
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):988-92. PubMed ID: 2158260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.
    Smith LJ; Glass M; Minkwitz MC
    Clin Pharmacol Ther; 1993 Oct; 54(4):430-6. PubMed ID: 8222486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics.
    Dahlén B; Zetterström O; Björck T; Dahlén SE
    Eur Respir J; 1994 Feb; 7(2):324-31. PubMed ID: 8162986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects.
    Taylor IK; O'Shaughnessy KM; Fuller RW; Dollery CT
    Lancet; 1991 Mar; 337(8743):690-4. PubMed ID: 1672176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers.
    O'Shaughnessy TC; Georgiou P; Howland K; Dennis M; Compton CH; Barnes NC
    Thorax; 1997 Jun; 52(6):519-22. PubMed ID: 9227717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist.
    Krell RD; Aharony D; Buckner CK; Keith RA; Kusner EJ; Snyder DW; Bernstein PR; Matassa VG; Yee YK; Brown FJ
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):978-87. PubMed ID: 2158259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet-activating factor-induced bronchoconstriction by the leukotriene D4 receptor antagonist ICI 204,219.
    Kidney JC; Ridge SM; Chung KF; Barnes PJ
    Am Rev Respir Dis; 1993 Jan; 147(1):215-7. PubMed ID: 8420421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma--A comparison with leukotriene D4 induced broncoconstriction.
    Schelfhout V; Van De Velde V; Pauwels R; Joos G
    Pulm Pharmacol Ther; 2008; 21(2):276-84. PubMed ID: 17611132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of an oral leukotriene antagonist L-649,923 on histamine and leukotriene D4-induced bronchoconstriction in normal man.
    Barnes N; Piper PJ; Costello J
    J Allergy Clin Immunol; 1987 May; 79(5):816-21. PubMed ID: 3553279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis.
    Donnelly AL; Glass M; Minkwitz MC; Casale TB
    Am J Respir Crit Care Med; 1995 Jun; 151(6):1734-9. PubMed ID: 7767514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist.
    Finnerty JP; Wood-Baker R; Thomson H; Holgate ST
    Am Rev Respir Dis; 1992 Apr; 145(4 Pt 1):746-9. PubMed ID: 1554195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma.
    Findlay SR; Barden JM; Easley CB; Glass M
    J Allergy Clin Immunol; 1992 May; 89(5):1040-5. PubMed ID: 1583246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular effects of leukotriene D4 in human skin.
    Bisgaard H
    J Invest Dermatol; 1987 Feb; 88(2):109-14. PubMed ID: 3805752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICI 198615 is an antagonist of leukotriene C4, leukotriene D4 and leukotriene E4 vasopressor responses in the conscious rat.
    Smith EF; Slivjak MJ
    Pharmacology; 1990; 41(2):57-66. PubMed ID: 2175920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotriene D4-induced increases in cytosolic calcium in THP-1 cells: dependence on extracellular calcium and inhibition with selective leukotriene D4 receptor antagonists.
    Chan CC; Ecclestone P; Nicholson DW; Metters KM; Pon DJ; Rodger IW
    J Pharmacol Exp Ther; 1994 Jun; 269(3):891-6. PubMed ID: 8014876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma.
    Makker HK; Lau LC; Thomson HW; Binks SM; Holgate ST
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1413-8. PubMed ID: 8389103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group.
    Spector SL; Smith LJ; Glass M
    Am J Respir Crit Care Med; 1994 Sep; 150(3):618-23. PubMed ID: 8087328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction.
    O'Shaughnessy KM; Taylor IK; O'Connor B; O'Connell F; Thomson H; Dollery CT
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1431-5. PubMed ID: 8389105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An examination of the influence of the epithelium on contractile responses to peptidoleukotrienes and blockade by ICI 204,219 in isolated guinea pig trachea and human intralobar airways.
    Buckner CK; Fedyna JS; Robertson JL; Will JA; England DM; Krell RD; Saban R
    J Pharmacol Exp Ther; 1990 Jan; 252(1):77-85. PubMed ID: 2153812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.